Zeiss Pharmaceuticals Private Limited

Zeiss Pharmaceuticals Private Limited - pharma in Nalagarh, Himachal Pradesh, India. FY 2026 financials & compliance.
CIN U24200HP2004PTC026909 Incorporated 11 March 2004 ROC Himachal Pradesh HQ Nalagarh, Himachal Pradesh, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2025
₹96.9 Cr
▲ 6% YoY
Net profit · FY 2025
₹27.4 Cr
Net margin 28.3%
EBITDA · FY 2025
₹48.31 Cr
EBITDA margin 49.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹8.4 Lakh
Issued & subscribed
Open charges
₹200.23 Cr
Satisfied ₹9.83 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
101
Provident fund records

About Zeiss Pharmaceuticals Private Limited

Data last updated:

Zeiss Pharmaceuticals Private Limited is a private limited company based in Nalagarh, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 March 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24200HP2004PTC026909. Its GSTIN is 02AAACZ2089F1ZI (Himachal Pradesh). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.4 Lakh. It is led by directors including Sat Pal and Vikas Gupta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nalagarh, Himachal Pradesh.

As per the financials filed for FY 2025, the company reported a revenue of ₹96.9 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹27.4 Cr (net margin 28.3%) and EBITDA of ₹48.31 Cr (EBITDA margin 49.9%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 13% over five years.

The company has about 101 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

As per MCA filings, the company has open charges of ₹200.23 Cr and satisfied charges of ₹9.83 Cr on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it; 2 cases are pending. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹2.35 Cr; the latest was in June 2023. Its 6 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Arene Life Sciences (Unit 4) Private Limited with revenue of ₹405.87 Cr. The company has 7 MSME Form 1 returns on record between 2019 and 2022, listing 788 overdue payments to 45 micro and small suppliers.

Zeiss Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0002905). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zeisspharma.com.

Company details

CIN U24200HP2004PTC026909
Registration Number 026909
Incorporation Date 11 March 2004
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HP-11-0002905

Recognitions & Rankings of Zeiss Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-HP-11-0002905

Contact details

Zeiss Pharmaceuticals Private Limited's registered office is in Nalagarh, Himachal Pradesh. Its website is zeisspharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No 72 – 73 Epip Pahse – I, Near Esi Dispensary Jharmajai Baddi Solan, Nalagarh, Himachal Pradesh, India – 173205
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Zeiss Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Zeiss Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Zeiss Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Zeiss Pharmaceuticals Private Limited, buy the company report.

Financials of Zeiss Pharmaceuticals Private Limited

FY 2025 filings available

Zeiss Pharmaceuticals Private Limited reported revenue of ₹96.9 Cr (up 6% YoY) for FY 2025.

Revenue · FY 2025
₹96.9 Cr ▲ 6%
Net profit · FY 2025
₹27.4 Cr margin 28.3%
EBITDA · FY 2025
₹48.31 Cr margin 49.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▼ 5%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 26%
5 years · compounded
▲ 63%

Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 6% growth in the latest year. EBITDA rose 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹96.9 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹48.31 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹27.4 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin49.9%
Net Profit Margin28.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Zeiss Pharmaceuticals Private Limited, buy the company report.

Board of directors of Zeiss Pharmaceuticals Private Limited

Zeiss Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sat PalDirector11 Mar 200422 Years 7 MonthsCurrent
Vikas GuptaDirector11 Mar 200422 Years 7 MonthsCurrent
Vinij GuptaDirector11 Mar 200422 Years 7 MonthsCurrent

Peer comparison

Zeiss Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Arene Life Sciences (Unit 4) Private Limited₹405.87 Cr (FY 2021)3.0%Hyderabad, Telangana, India
United Biotech Private Limited₹404.94 Cr (FY 2024)27.0%New Delhi, Delhi, India
Torque Pharmaceuticals Private Limited₹404.13 Cr (FY 2024)1.0%Chandigarh, India
Steril-Gene Life Sciences Private Limited₹404.06 Cr (FY 2025)41.0%Chennai, Tamil Nadu, India
Gland Chemicals Pvt Ltd₹401.18 Cr (FY 2022)33.0%Hyderabad, Telangana, India
Maiva Pharma Private Limited₹399.05 Cr (FY 2025)38.0%Bangalore, Karnataka, India
Zeiss Pharmaceuticals Private Limitedthis company₹96.9 Cr (FY 2025)₹27.4 Cr28.3%6.0%101Nalagarh, Himachal Pradesh, India

To see the full peer comparison of Zeiss Pharmaceuticals Private Limited, buy the company report.

Auditor

Zeiss Pharmaceuticals Private Limited is audited by VINEY GOEL & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
VINEY GOEL & ASSOCIATESFY 2023012188N

Shareholding

The shareholding of Zeiss Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Zeiss Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹200.23 Cr
Satisfied charges
₹9.83 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹200.23 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Mar 2024100875705Hdfc Bank Limited₹10 CrOpen
10 Feb 2024100881385Hdfc Bank Limited₹10 CrOpen
19 Dec 201510614312Hdfc Bank Limited₹180.23 CrOpen
30 Jul 200810121371Axis Bank Limited₹4.25 CrSatisfied
18 Aug 200710068942Member Secretary₹2.33 CrSatisfied

To see the full charge records of Zeiss Pharmaceuticals Private Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Zeiss Pharmaceuticals Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹2.35 Cr; the latest was in June 2023.

Total deals
6
Secondary share transfers
4
Funding rounds
2
Disclosed funding
₹2.35 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Jun 2023Secondary share transferUndisclosedBuyer: an individual
Seller: Sbjb Dynasty Trust
Jun 2023Secondary share transferUndisclosedBuyer: an individual
Seller: Sbjb Dynasty Trust
Jun 2023Secondary share transferUndisclosedBuyer: an individual
Seller: Sbjb Dynasty Trust
Nov 2018Secondary share transferUndisclosedBuyer: Sbjb Dynasty Trust
Seller: an individual
Apr 2007Funding round₹1.32 CrInvestors: an individual

To see the full deal history of Zeiss Pharmaceuticals Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Zeiss Pharmaceuticals Private Limited has 7 MSME Form 1 returns on record between 2019 and 2022, listing 788 overdue payments to 45 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 45)

SupplierAmount dueDue sinceReported on
Axenic Print Pack
Kartonz
Artpack Industries
an individual supplier
an individual supplier

To see the full MSME payment records of Zeiss Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Zeiss Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Zeiss Pharma LimitedU24233HR2014PLC052139

To see the full group structure of Zeiss Pharmaceuticals Private Limited, buy the company report.

Employees & EPFO

Zeiss Pharmaceuticals Private Limited has a workforce of 101 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.

Employee count
101
Active EPFO establishments
1
Employee growth
26.25%

GST

Zeiss Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
02AAACZ2089F1ZIHimachal PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Zeiss Pharmaceuticals Private Limited, buy the company report.

Recent activity

Zeiss Pharmaceuticals Private Limited has 3 board changes on record since 2004: 3 appointments. The latest: Sat Pal was appointed as Director on 11 Mar 2004.

AGM
Zeiss Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Zeiss Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh.
Charges
A charge with Hdfc Bank Limited of Rs. 18,022.78 Lakh registered on 19 Dec 2015 with Charge ID 10614312 was modified on 13 Mar 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,000.00 Lakh with Charge ID 100875705 was registered on 04 Mar 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,000.00 Lakh with Charge ID 100881385 was registered on 10 Feb 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 18,022.78 Lakh with Charge ID 10614312 was registered on 19 Dec 2015.
Charges
A charge registered on 18 Aug 2007 via Charge ID 10068942 with Member Secretary was fully satisfied on 30 Apr 2015.
Charges
A charge registered on 30 Jul 2008 via Charge ID 10121371 with Axis Bank Limited was fully satisfied on 23 Apr 2015.
Charges
A charge with Axis Bank Limited of Rs. 425.00 Lakh registered on 30 Jul 2008 with Charge ID 10121371 was modified on 24 Oct 2008.
Charges
A charge registered on 13 May 2005 via Charge ID 90174537 with State Bank Of Patiala was fully satisfied on 29 Aug 2008.
Charges
A charge with Axis Bank Limited amounted to Rs. 425.00 Lakh with Charge ID 10121371 was registered on 30 Jul 2008.
Charges
A charge with Member Secretary amounted to Rs. 232.63 Lakh with Charge ID 10068942 was registered on 18 Aug 2007.

6 earlier events are in the company report.

Frequently asked questions

Zeiss Pharmaceuticals is an active private limited company based in Nalagarh, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 March 2004 (22+ years old) and is registered under CIN U24200HP2004PTC026909.

Zeiss Pharmaceuticals has 3 current directors:

The latest financial statements of Zeiss Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Zeiss Pharmaceuticals is 02AAACZ2089F1ZI, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Zeiss Pharmaceuticals is U24200HP2004PTC026909. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Zeiss Pharmaceuticals has 5 court cases on record: 2 filed by the company and 3 filed against it. 2 are pending. Most are in the high courts.

Zeiss Pharmaceuticals was incorporated on 11 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.

Zeiss Pharmaceuticals has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹2.35 Cr; the latest was in June 2023.

The peers of Zeiss Pharmaceuticals by revenue are Arene Life Sciences (Unit 4) Private Limited, United Biotech Private Limited, Torque Pharmaceuticals Private Limited, Steril-Gene Life Sciences Private Limited, Gland Chemicals Pvt Ltd and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Sat Pal was appointed as Director on 11 Mar 2004. Vikas Gupta was appointed as Director on 11 Mar 2004. Vinij Gupta was appointed as Director on 11 Mar 2004.

Yes, Zeiss Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0002905).

Zeiss Pharmaceuticals has 7 MSME Form 1 returns on record between 2019 and 2022, listing 788 overdue payments to 45 micro and small suppliers. The latest return was filed on 15 Nov 2022.